DSC127 + placebo vehicle gel + Standard of Care gel, Aquasite
Phase 3Terminated 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetic Foot Ulcers
Conditions
Diabetic Foot Ulcers
Trial Timeline
Apr 1, 2013 → Dec 1, 2015
NCT ID
NCT01849965About DSC127 + placebo vehicle gel + Standard of Care gel, Aquasite
DSC127 + placebo vehicle gel + Standard of Care gel, Aquasite is a phase 3 stage product being developed by Integra LifeSciences for Diabetic Foot Ulcers. The current trial status is terminated. This product is registered under clinical trial identifier NCT01849965. Target conditions include Diabetic Foot Ulcers.
What happened to similar drugs?
20 of 20 similar drugs in Diabetic Foot Ulcers were approved
Approved (20) Terminated (3) Active (0)
Hype Score Breakdown
Clinical
17
Activity
0
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01849965 | Phase 3 | Terminated |
Competing Products
20 competing products in Diabetic Foot Ulcers